Unravelling the causal relationship between endometriosis and the risk for developing venous thromboembolism: a pooled analysis

Pauline De Corte,Igor Milhoranca,Sylvia Mechsner,Sara Anna Öberg,Tobias Kurth,Klaas Heinemann
DOI: https://doi.org/10.1055/a-2407-9498
2024-09-02
Abstract:Objective: To investigate the effect of endometriosis on Venous Thromboembolism (VTE) in Oral Contraceptives (OCs) users. Design: Pooled analysis on a harmonized dataset compromising international patient-centric cohort studies: INAS-VIPOS, INAS-SCORE, and INAS-FOCUS. Setting: 11 European countries, the US, and Canada Population: Individuals being newly prescribed an OC with or without an endometriosis and no VTE history. Methods: Detailed information was captured using self-administered questionnaires at baseline and every 6-12 months thereafter. Self-reported VTEs were medically validated and reviewed by an independent adjudication committee. Incidence rates (IR) were calculated per 10,000 woman-years. The association of endometriosis on VTE was determined in a time-to-event analysis, calculating crude and adjusted Hazard Ratios (HRs) with 95% confidence intervals (CI) using stabilized inverse probability of treatment weighting (IPTW). Results: A total of 22,072 women had an endometriosis diagnosis, and 91,056 women did not. Women with endometriosis contributed 78,751 woman-years during which 41 VTE events occurred (IR: 5.2/10,000, 95% CI: 3.7-7.1) compared to 127 VTEs during 310,501 woman-years in women without endometriosis (IR 4.1/10,000, 95% CI: 3.4-4.9). The HR of VTE in women with endometriosis was 1.79 (95% CI: 1.24-2.57) using stabilized IPTW controlling for age, BMI, smoking, education, age at menarche, and family history of VTE. Subgroup and sensitivity analyses showed similar results. Conclusions: These results highlight the importance of considering endometriosis as a potential factor contributing to VTE in women using OC however, further research on the relationship between endometriosis and VTE is warranted. Funding: No funding. Key words: Endometriosis, Venous Thromboembolism.
What problem does this paper attempt to address?